T4453 |
JD-5037
|
1392116-14-1
|
98.87%
|
|
JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.
|
T8975 |
PSB-SB-487
|
1399049-81-0
|
98.78%
|
|
PSB-SB-487 is antagonist of GPR55.
|
T14046 |
Anandamide
|
94421-68-8
|
98.76%
|
|
Anandamide ((5Z,8Z,11Z,14Z)-N-(2-Hydroxyethyl)icosa-5,8,11,14-tetraenamide), an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also ...
|
T2S0271 |
Voacamine
|
3371-85-5
|
98.73%
|
|
Voacamine (Voacanginine) is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein ...
|
T6755 |
AM1241
|
444912-48-5
|
98.72%
|
|
AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.
|
T19094 |
2,3-Butanediol
|
513-85-9
|
98.64%
|
|
2,3-Butanediol is a butanediol derived from the bioconversion of natural resources which has great potential for diverse industries, including chemical, cosmetic...
|
T29930 |
AM-1235
|
335161-27-8
|
98.62%
|
|
AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.
|
T7316 |
LY2828360
|
1231220-79-3
|
98.61%
|
|
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100,000 nM, ...
|
T62761 |
CB1 agonist 1
|
851212-80-1
|
98.56%
|
|
CB1 agonist 1 is a potent CB1 agonist with a pIC50 value of 5.7 for CB1 receptors.CB1 agonist 1 can be used to study brain disorders, pain, and inflammation.
|
T41230 |
CB 65
|
913534-05-1
|
98.39%
|
|
CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.
|
T28468 |
PSNCBAM-1
|
877202-74-9
|
98.18%
|
|
PSNCBAM-1 (PSNCBAM 1) is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies....
|
T61562 |
CB1R Allosteric modulator 3
|
2633686-36-7
|
98.18%
|
|
CB1R Allosteric modulator 3 is a potent CB1R modulator.CB1R Allosteric modulator 3 inhibits cAMP and β-Arrestin, and can be used for the study of obesity and nic...
|
T37075 |
CB2R PAM
|
2244579-87-9
|
98.17%
|
|
CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive mutational modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]G...
|
T22009 |
CB2 receptor agonist 2
|
1314230-75-5
|
98.07%
|
|
CB2 receptor agonist 2 (ZINC72105556) is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high a...
|
T1519L |
Rimonabant
|
168273-06-1
|
98%
|
|
Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its m...
|
T2635 |
Org 27569
|
868273-06-7
|
98%
|
|
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and e...
|
T5996 |
CB1-IN-1
|
1429239-98-4
|
98%
|
|
CB1-IN-1 (DBPR211) is a peripherally restricted CB1R antagonist, for CB1R and CB2R with Ki of 0.3 nM and 21 nM,respectively.
|
T3699 |
Bay 59-3074
|
406205-74-1
|
98%
|
|
Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of chronic neuropathic and inflammatory pain, it displays anti-hyperalgesic a...
|
T7375 |
A-836339
|
959746-77-1
|
98%
|
|
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 recep...
|
T3S0738 |
Yangonin
|
500-62-9
|
98%
|
|
Yangonin (Y100550) is a novel CB receptor ligand, it exhibits affinity for the human recombinant CB receptor. Yangonin (Y100550) could be a valuable candidate fo...
|